Staff and Admin costs over $6m for the Qtr.
Sales (excl R&D money received) $3.2m
No customers that have signed for the new approved FDA entoeriic testing kits. "Hopeful that customers will sign up"
The new CEO needs to really show some leadership here-
- restructure of staff and admin costs going forward. This isn't sustainable running wages and admin @200% of sales.
- get these Hospitals to sign and and use these as test cases moving forward (even it means supplying product at cost for 6-12 months)
- create a pipeline of future roll outs....
Not sure about this company - give them 6 months to start showing results!
- Forums
- ASX - By Stock
- GSS
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
GSS
genetic signatures limited
Add to My Watchlist
1.37%
!
37.0¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
0.005(1.37%) |
Mkt cap ! $84.04M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 36.5¢ | $20.27K | 55.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 0.370 |
2 | 3407 | 0.360 |
1 | 40000 | 0.355 |
4 | 130509 | 0.350 |
1 | 1683 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
0.480 | 500 | 1 |
Last trade - 13.36pm 14/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |